Zai Lab Ltd

Stock Chart, Company Information, and Scan Results

$17.15(as of Jun 2, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Zai Lab Ltd Company Information, Fundamentals, and Technical Indicators

Stock Price$17.15
Ticker SymbolZLAB
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees1,784
CountyUSA
Market Cap$1,843.2M
EBIDTA-227.0M
10-Day Moving Average18.24
P/E Ratio-10.66
20-Day Moving Average19.11
Forward P/E Ratio0.00
50-Day Moving Average20.27
Earnings per Share-1.70
200-Day Moving Average22.82
Profit Margin-51.22%
RSI34.03
Shares Outstanding112.4M
ATR0.95
52-Week High44.34
Volume1,768,813
52-Week Low15.96
Most Recent Support Level18.25
Book Value662.0M
Most Recent Resistance Level18.78
P/B Ratio2.87
Upper Keltner21.24
P/S Ratio4.19
Lower Keltner16.97
Debt-to-Equity Ratio21.24
Next Earnings Date08/05/2026
Cash Surplus258.3M
Next Ex-Dividend DateUnknown

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company has a strategic collaboration with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.

Zai Lab Ltd In Our Stock Scanner

As of Jun 03, 2026
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Hammer CandleScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Dragonfly DojiScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.